Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cells

Journal of Cellular Biochemistry

Volumn 88, Issue 3, 2003, Pages 609-622

  Leman, Eddy S ^a   Getzenberg, Robert H ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Androgen and vitamin D receptors; Normal prostate; Vitamin D

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CALCITRIOL; STEROID; VITAMIN D RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; DNA BINDING; DRUG ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEWBORN; PRIORITY JOURNAL; PROSTATE; RECEPTOR BINDING;

ANIMALS; CALCITRIOL; CELL FRACTIONATION; CELL LINE; CELL NUCLEUS; CYTOPLASM; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; PROSTATE; RECEPTORS, ANDROGEN; RECEPTORS, CALCITRIOL;

EID: 0037441473     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10371     Document Type: Article

References (32)

1. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW. 1988. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298.
2. Barletta F, Freedman LP, Christakos S. 2002. Enhancement of VDR-mediated transcription by phosphorylation: Correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Mol Endocrinol 16:301-314.
3. Buitrago C, Vazquez G, De Boland AR, Boland RL. 2000. Activation of Src kinase in skeletal muscle cells by 1, 1,25-(OH(2))-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. J Cell Biochem 79:274-281.
4. Colston K, Colston MJ, Feldman D. 1981. 1,25-Dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083-1086.
5. Desai RK, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 1995. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: Effects of perturbing phosphorylation pathways by okadaic acid and staurosporine. Endocrinology 136:5685-5693.
6. Haussler MR. 1986. Vitamin D receptors: Nature and function. Annu Rev Nutr 6:527-562.
7. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349.
8. Hilliard GMt, Cook RG, Weigel NL, Pike JW. 1994. 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: Site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry 33:4300-4311.
9. Hsieh T, Wu JM. 1997. Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate-specific antigen by 1alpha,25-dihydroxyvitamin D3 in androgen-responsive LNCaP cells. Biochem Biophys Res Commun 235:539-544.
10. Hsieh TY, Ng CY, Mallouh C, Tazaki H, Wu JM. 1996. Regulation of growth, PSA/PAP, and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells. Biochem Biophys Res Commun 223:141-146.
11. Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, Galligan MA, Haussler CA, Haussler MR. 2002. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J Cell Biochem 85:435-457.
12. Kallay E, Pietschmann P, Toyokuni S, Bajna E, Hahn P, Mazzucco K, Bieglmayer C, Kato S, Cross HS. 2001. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 22:1429-1435.
13. Kivineva M, Blauer M, Syvala H, Tammela T, Tuohimaa P. 1998. Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate. J Steroid Biochem Mol Biol 66:121-127.
14. Konety BR, Schwartz GG, Acierno JS, Jr., Becich MJ, Getzenberg RH. 1996. The role of vitamin D in normal prostate growth and differentiation. Cell Growth Differ 7:1563-1570.
15. Konety BR, Nangia AK, Nguyen TS, Thomas A, Getzenberg RH. 1999. Effect of prenatal vitamin D (calcitriol) exposure on the growth and development of the prostate. Prostate 41:181-189.
16. Konety BR, Leman E, Vietmeier B, Arlotti J, Dhir R, Getzenberg RH. 2000. In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and prepubertal prostate. J Urol 164:1812-1818.
17. Krill D, Stoner J, Konety BR, Becich MJ, Getzenberg RH. 1999. Differential effects of vitamin D on normal human prostate epithelial and stromal cells in primary culture. Urology 54:171-177.
18. Langub MC, Reinhardt TA, Horst RL, Malluche HH, Koszewski NJ. 2000. Characterization of vitamin D receptor immunoreactivity in human bone cells. Bone 27:383-387.
19. Makela S, Santti R, Martikainen P, Nienstedt W, Paranko J. 1990. The influence of steroidal and nonsteroidal estrogens on the 5 alpha-reduction of testosterone by the ventral prostate of the rat. J Steroid Biochem 35:249-256.
20. Mangelsdorf DJ, Koeffier HP, Donaldson CA, Pike JW, Haussler MR. 1984. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398.
21. McLane JA, Katz M, Abdelkader N. 1990. Effect of 1,25-dihydroxyvitamin D3 on human keratinocytes grown under different culture conditions. In Vitro Cell Dev Biol 26:379-387.
22. Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P. 1992. The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Cancer Res 52:515-520.
23. Miller GJ, Stapleton GE, Hedlund TE, Moffat KA. 1995. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha, 25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1:997-1003.
24. Nangia AK, Butcher JL, Konety BR, Vietmeier BN, Getzenberg RH. 1998. Association of vitamin D receptors with the nuclear matrix of human and rat genitourinary tissues. J Steroid Biochem Mol Biol 66:241-246.
25. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. 1994. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54:805-810.
26. Schulze H, Claus S. 1990. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16:331-343.
27. Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR. 1995. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo. Urology 46:365-369.
28. Skowronski RJ, Peehl DM, Feldman D. 1993. Vitamin D and prostate cancer: 1,25 Dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines. Endocrinology 132:1952-1960.
29. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T. 1982. 1 Alpha, 25-dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J 204:713-719.
30. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G. 1988. Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch A Pathol Anat Histopathol 412:387-391.
31. Zhao XY, Ly LH, Peehl DM, Feldman D. 1999. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells. Endocrinology 140:1205-1212.
32. Zhao XY, Peehl DM, Navone NM, Feldman D. 2000. 1Alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Endocrinology 141:2548-2556.